Skip to Main Content

Paper Details

Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study.
Eur Urol
24
2023
Author NameAffiliation
Evan Y YuUniversity of Washington and Fred Hutchinson Cancer Center
Ali TafreshiUniversity of Wollongong
Johann S de BonoThe Institute of Cancer Research and the Royal Marsden
  • 1 - 3

Datasets

Release 1.2